Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea · Delayed Price · Currency is KRW 5,210.00
-150.00 (-2.80%)
At close: Jun 19, 2026
Sinil Pharmaceutical Market Cap
Sinil Pharmaceutical has a market cap or net worth of 59.27 billion as of June 18, 2026. Its market cap has decreased by -21.89% in one year.
Market Cap
59.27B
Enterprise Value
21.23B
Revenue
82.18B
Ranking
n/a
PE Ratio
8.66
Stock Price
5,210.00
Market Cap Chart
Since November 20, 2000, Sinil Pharmaceutical's market cap has increased from 16.83B to 59.27B, an increase of 252.23%. That is a compound annual growth rate of 5.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 59.27B | -14.17% |
| Dec 30, 2025 | 69.05B | -5.60% |
| Dec 30, 2024 | 73.15B | -16.60% |
| Dec 28, 2023 | 87.71B | -9.43% |
| Dec 29, 2022 | 96.84B | -24.53% |
| Dec 30, 2021 | 128.31B | -48.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharos iBio | 81.04B |
| Daehan Nupharm | 79.58B |
| Organoidsciences | 71.72B |
| GL Pharm Tech | 69.72B |
| Optipharm.CO.,LTD | 68.73B |
| Hwail Pharmaceutical | 68.60B |
| Sinsin Pharmaceutical | 68.42B |
| Polaris AI Pharma | 68.41B |